Targeting ischemic brain injury with intravenous immunoglobulin.
about
Protective effects of incensole acetate on cerebral ischemic injury.Pathophysiology, treatment, and animal and cellular models of human ischemic stroke.The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysis.Neuroprotection in stroke by complement inhibition and immunoglobulin therapy.Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic strokeEffects and mechanisms of chinese herbal medicine in ameliorating myocardial ischemia-reperfusion injury.Intravenous immunoglobulin protects neurons against amyloid beta-peptide toxicity and ischemic stroke by attenuating multiple cell death pathways.Advances in diagnosing and managing antibody-mediated rejection.Regulation of immunity and inflammation by intravenous immunoglobulin: relevance to solid organ transplantation.Evidence that NF-κB and MAPK Signaling Promotes NLRP Inflammasome Activation in Neurons Following Ischemic Stroke.Semax, an analog of ACTH(4-7), regulates expression of immune response genes during ischemic brain injury in rats.Motoneuronotrophic factor analog GM6 reduces infarct volume and behavioral deficits following transient ischemia in the mouseIVIG activates FcγRIIB-SHIP1-PIP3 Pathway to stabilize mast cells and suppress inflammation after ICH in mice.Hexahydrocurcumin protects against cerebral ischemia/reperfusion injury, attenuates inflammation, and improves antioxidant defenses in a rat stroke model.The role of intravenous immunoglobulin in the treatment of cerebral vasospasm induced by subarachnoid haemorrhage: an experimental study.The role of NLRP3 inflammasome in stroke and central poststroke pain
P2860
Q34250174-933B08D7-9823-40F7-B2A6-E416BCC8B94BQ34569654-3B4ACCC0-413D-498E-B49C-2D53E54CB102Q35128868-E6AE9519-FED2-4C18-A1C0-C118384F68DCQ37091310-790D4373-C9C3-49A9-917F-1C15A58B05F8Q37212005-A7CF7ADA-7177-40AC-B5F6-197EC5879028Q37322737-F195E484-49CD-4D2F-B2A8-4A3902D14D55Q37487547-24EF94D2-68EB-412E-AB87-0F7B136422DEQ37676032-BFD883AF-CF5C-4C84-B07B-DEB830B1C75DQ37877263-AC8BB9B7-5ECF-44F3-9404-AB67D63C8380Q38769999-99E3CB62-6144-4DFB-9A63-C119039A0A5BQ38931847-278BB1D7-D342-43D7-926C-FC3606BACF30Q40967475-7C2FE91F-C995-46FD-AC86-EAC43E734E14Q43805225-2812C662-540E-4AE2-9161-432F3EF86197Q47116983-634F3BCF-1A13-46BF-B9CD-7F4D0FABFE7EQ49064990-C566FA7A-54B5-4C2E-91B7-628AC045E1CAQ58768826-7C1FC86B-C417-4867-8954-1C7F4B72CE29
P2860
Targeting ischemic brain injury with intravenous immunoglobulin.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeting ischemic brain injury with intravenous immunoglobulin.
@en
Targeting ischemic brain injury with intravenous immunoglobulin.
@nl
type
label
Targeting ischemic brain injury with intravenous immunoglobulin.
@en
Targeting ischemic brain injury with intravenous immunoglobulin.
@nl
prefLabel
Targeting ischemic brain injury with intravenous immunoglobulin.
@en
Targeting ischemic brain injury with intravenous immunoglobulin.
@nl
P2860
P356
P1476
Targeting ischemic brain injury with intravenous immunoglobulin.
@en
P2093
Pradeep K Selvaraj
Thiruma V Arumugam
P2860
P356
10.1517/14728222.12.1.19
P407
P577
2008-01-01T00:00:00Z